HUM · NYSE
Humana (HUM) Stock Price & Fundamentals
Humana (HUM) closed at $1,039.48 on Oct 9, 2026, down 1.24% from the previous close of $1,052.53.
Share price, past year
1Y +34.38%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,039.48 |
| Sep 30, 2026 | $1,041.23 |
| Aug 31, 2026 | $1,021.73 |
| Jul 31, 2026 | $942.97 |
| Jun 30, 2026 | $962.70 |
| May 29, 2026 | $911.90 |
| Apr 30, 2026 | $885.41 |
| Mar 31, 2026 | $906.58 |
| Feb 27, 2026 | $861.60 |
| Jan 30, 2026 | $821.80 |
| Dec 31, 2025 | $776.62 |
| Nov 28, 2025 | $734.55 |
| Oct 31, 2025 | $745.88 |
Key statistics
- Market cap
- —
- P/E (TTM)
- 39.6
- EPS (TTM)
- $26.26
- Revenue (TTM)
- $137.20B
- Net income (TTM)
- $1.13B
- Shares outstanding
- —
- Dividend yield
- 0.34%
- 52-week range
- $726.91 – $1,052.53
Financials
Humana reported revenue of $129.66B for fiscal 2025, up 10.11% from fiscal 2024.
Humana earned net income of $1.19B in fiscal 2025, a net margin of 0.9%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $129.66B | +10.1% | $1.19B | 0.9% | $9.84 | $375.00M |
| FY2024ended Dec 31, 2024 | $117.76B | +10.7% | $1.21B | 1.0% | $9.98 | $2.39B |
| FY2023ended Dec 31, 2023 | $106.37B | +14.5% | $2.49B | 2.3% | $20.00 | $2.98B |
| FY2022ended Dec 31, 2022 | $92.87B | +11.8% | $2.81B | 3.0% | $22.08 | $3.45B |
| FY2021ended Dec 31, 2021 | $83.06B | +7.7% | $2.93B | 3.5% | $22.67 | $920.00M |
| FY2020ended Dec 31, 2020 | $77.16B | +18.9% | $3.37B | 4.4% | $25.31 | $4.68B |
| FY2019ended Dec 31, 2019 | $64.89B | +14.0% | $2.71B | 4.2% | $20.10 | $4.55B |
| FY2018ended Dec 31, 2018 | $56.91B | +5.9% | $1.68B | 3.0% | $12.16 | $1.56B |
| FY2017ended Dec 31, 2017 | $53.77B | −1.1% | $2.45B | 4.6% | $16.81 | $3.53B |
| FY2016ended Dec 31, 2016 | $54.38B | — | $614.00M | 1.1% | $4.07 | $1.41B |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | $39.65B | $1.19B | $9.83 |
| Q4 FY2025ended Dec 31, 2025 | $32.52B | −$796.00M | — |
| Q3 FY2025ended Sep 30, 2025 | $32.65B | $195.00M | $1.62 |
| Q2 FY2025ended Jun 30, 2025 | $32.39B | $545.00M | $4.51 |
| Q1 FY2025ended Mar 31, 2025 | $32.11B | $1.24B | $10.30 |
| Q4 FY2024ended Dec 31, 2024 | $29.21B | −$693.00M | — |
| Q3 FY2024ended Sep 30, 2024 | $29.40B | $480.00M | $3.98 |
| Q2 FY2024ended Jun 30, 2024 | $29.54B | $679.00M | $5.62 |
Company profile
- Name
- Humana Inc.
- Ticker
- HUM
- Exchange
- NYSE
- Industry (SEC SIC)
- Hospital & Medical Service Plans
- Headquarters
- 101 E. Main Street, Louisville, KY
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000049071
Recent SEC filings
- Sep 1, 2026
- Jul 29, 2026
- Jul 29, 2026
- Jul 29, 2026
- Jun 1, 2026
- May 19, 2026
- Apr 29, 2026
- Apr 29, 2026
Frequently asked questions
What is Humana's stock price?
Humana (HUM) closed at $1,039.48 on Oct 9, 2026, down 1.24% from the previous close of $1,052.53.
How much revenue does Humana make?
Humana reported revenue of $129.66B for fiscal 2025, up 10.11% from fiscal 2024.
What is HUM's P/E ratio?
Humana's price-to-earnings ratio is 39.6, based on trailing twelve-month diluted EPS of $26.26.
Does Humana pay a dividend?
Yes. Humana declared $3.54 per share in dividends over the last four quarters, a yield of 0.34%.
Sources and methodology
Fundamentals come from Humana Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures